We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Marginal zone lymphomas: a consensus practice statement from the Australasian Lymphoma Alliance.
- Authors
Lasica, Masa; Anderson, Mary A.; Boussioutas, Alex; Gregory, Gareth P.; Hamad, Nada; Manos, Kate; McKelvie, Penny; Ng, Michael; Campbell, Belinda; Palfreyman, Emma; Salvaris, Ross; Weinkove, Robert; Wight, Joel; Opat, Stephen; Tam, Constantine
- Abstract
Marginal zone lymphomas (MZLs) are a rare, indolent group of non‐Hodgkin lymphomas with different diagnostic, genetic and clinical features and therapeutic implications. The most common is extranodal MZL of mucosa‐associated lymphoid tissue, followed by splenic MZL and nodal MZL. Patients with MZL generally have good outcomes with long survival rates but frequently have a relapsing/remitting course requiring several lines of therapy. The heterogeneous presentation and relapsing course present the clinician with several diagnostic and therapeutic challenges. This position statement presents evidence‐based recommendations in the setting of Australia and New Zealand.
- Subjects
NEW Zealand; AUSTRALIA; CONSENSUS (Social sciences); MEDICAL protocols; NON-Hodgkin's lymphoma; CANCER relapse; TREATMENT effectiveness; SYMPTOMS
- Publication
Internal Medicine Journal, 2024, Vol 54, Issue 6, p1017
- ISSN
1444-0903
- Publication type
Article
- DOI
10.1111/imj.16390